Adamas Pharma
(ADMS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADMS | ASMB | SLGL | ||
| Company | Adamas Pharma | Assembly Biosciences | Sol-Gel Technologies Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 8.24 | 27.40 | 65.39 | ||
| High | 8.25 | 27.40 | 76.80 | ||
| Low | 8.18 | 25.47 | 65.28 | ||
| Latest | 8.22 | 26.09 | 76.12 | ||
| Change | +0.06 | -1.27 | +10.02 | ||
| % Change | +0.74% | -4.64% | +15.16% | ||
| Volume | 3,151,400 | 101,600 | 24,700 | ||
| 20-Day Average Volume | 834,440 | 99,690 | 27,180 | ||
| Previous Close | 8.16 | 27.36 | 66.10 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 8.16 | 27.10 | 64.66 | ||
| 20-Day Raw Stochastic | 86.36% | 18.53% | 97.62% | ||
| 20-Day Relative Strength | 73.46 | 41.25 | 70.79 | ||
| Weighted Alpha | +22.54 | +56.70 | +586.13 | ||
| Today's Opinion | 100% Buy | 8% Sell | 100% Buy | ||
| Previous Opinion | 96% Buy | 8% Sell | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 40% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.86% since 11/16/21 | +2.76% since 02/05/26 | +17.65% since 02/05/26 | ||
| Low | 8.15 on 11/17/21 | 25.47 on 02/12/26 | 60.55 on 02/09/26 | ||
| High | 8.25 on 11/23/21 | 27.50 on 02/11/26 | 76.80 on 02/12/26 | ||
| 1-Month | |||||
| %Chg | +2.62% since 10/22/21 | -15.65% since 01/12/26 | +20.84% since 01/12/26 | ||
| Low | 8.00 on 10/25/21 | 24.67 on 01/30/26 | 48.26 on 01/23/26 | ||
| High | 8.25 on 11/23/21 | 32.31 on 01/15/26 | 76.80 on 02/12/26 | ||
| 3-Month | |||||
| %Chg | +77.54% since 08/23/21 | -27.22% since 11/12/25 | +141.65% since 11/12/25 | ||
| Low | 4.41 on 08/27/21 | 24.67 on 01/30/26 | 28.81 on 11/13/25 | ||
| High | 8.25 on 11/23/21 | 39.71 on 11/20/25 | 76.80 on 02/12/26 | ||
| 6-Month | |||||
| %Chg | +57.47% since 05/21/21 | +8.75% since 08/12/25 | +399.15% since 08/12/25 | ||
| Low | 4.02 on 08/16/21 | 20.23 on 09/17/25 | 14.78 on 08/14/25 | ||
| High | 8.25 on 11/23/21 | 39.71 on 11/20/25 | 76.80 on 02/12/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 376,369 | 432,753 | 184,141 | ||
| Shares Outstanding, K | 45,787 | 15,817 | 2,786 | ||
| Annual Sales | 74,460,000 | 28,520,000 | 11,540,000 | ||
| Annual Net Income | -57,400,000 | -40,180,000 | -10,580,000 | ||
| Last Quarter Sales | 25,900,000 | 10,790,000 | 400,000 | ||
| Last Quarter Net Income | -19,520,000 | -9,200,000 | -5,940,000 | ||
| 60-Month Beta | 2.82 | 1.13 | 1.36 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/10/21 | -0.72 on 11/10/25 | -2.13 on 11/20/25 | ||
| Latest Earnings Date | 02/22/22 | 03/19/26 | 05/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||